GlassScriptPhysician profile
Payal P Patel
NPI 1144308776
$813.52
in general payments reported to CMS, 2019-2025
11 companies · $118 in 2025
The $118 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.61 · 2020: $84.57 · 2021: $116 · 2022: $199 · 2023: $150 · 2024: $69.61 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $154.85 | 2019-2024 | Doc Band |
| Pfizer INC. | $138.72 | 2019-2024 | |
| Xeris Pharmaceuticals, INC. | $111.86 | 2022 | |
| Abbvie INC. | $100.66 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $83.16 | 2025 | Airsupra |
| Sanofi-Aventis U.S. LLC | $59.21 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $50.49 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaqta |
| Glaxosmithkline, LLC. | $43.32 | 2020-2023 | Pediarix, Bexsero |
| Phadia US INC. | $32.78 | 2022-2023 | Immunocap |
| Verrica Pharmaceuticals INC. | $24.55 | 2023 | Ycanth |
| Sanofi Pasteur INC. | $13.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Payal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.